Patent AnalyticsExaminers
Rankings

Company or institution

VENTIRX PHARMACEUTICALS, INC.

12 applicationsfiled 2009 to 2018

Allowance rate
50%
−25 pts vs the USPTO range 25% to 75%
Rejections before allowance
1.7
level with the USPTO
Months to first action
17.8 mo
−0.8 vs the USPTO
Needed an RCE
42%
+15 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations8 apps
C07D Heterocyclic compounds3 apps
A61P Therapeutic activity of compounds1 apps

Art units

16423 apps
16243 apps
16732 apps
16282 apps
16271 apps
16931 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
15771662USE OF TLR8 AGONISTS TO TREAT CANCER2018-04-27Abandoned2017.1 mo
15290873METHODS OF ENHANCING ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY2016-10-11Abandoned410.7 mo
14977129TOLL-LIKE RECEPTOR AGONIST FORMULATIONS AND THEIR USE2015-12-21Abandoned1015.7 mo
15929758Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15914975Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15925551Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15824535Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15950781Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15340820Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15764259Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 12 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in